Smith & Nephew plc (BVMF:S1NN34)

Market Cap	77.30B
Revenue (ttm)	32.56B
Net Income (ttm)	2.69B
Shares Out	n/a
EPS (ttm)	3.06
PE Ratio	28.74
Forward PE	14.97
Dividend	0.78 (2.15%)
Ex-Dividend Date	Oct 2, 2025

Volume	11
Average Volume	81
Open	36.58
Previous Close	n/a
Day's Range	36.40 - 36.58
52-Week Range	29.13 - 40.88
Beta	0.66
RSI	56.71
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1856
• Employees: 17,349
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: S1NN34

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD